• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺肿瘤的外科与分子病理学

Surgical and molecular pathology of pancreatic neoplasms.

作者信息

Hackeng Wenzel M, Hruban Ralph H, Offerhaus G Johan A, Brosens Lodewijk A A

机构信息

Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Diagn Pathol. 2016 Jun 7;11(1):47. doi: 10.1186/s13000-016-0497-z.

DOI:10.1186/s13000-016-0497-z
PMID:27267993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4897815/
Abstract

BACKGROUND

Histologic characteristics have proven to be very useful for classifying different types of tumors of the pancreas. As a result, the major tumor types in the pancreas have long been classified based on their microscopic appearance.

MAIN BODY

Recent advances in whole exome sequencing, gene expression profiling, and knowledge of tumorigenic pathways have deepened our understanding of the underlying biology of pancreatic neoplasia. These advances have not only confirmed the traditional histologic classification system, but also opened new doors to early diagnosis and targeted treatment.

CONCLUSION

This review discusses the histopathology, genetic and epigenetic alterations and potential treatment targets of the five major malignant pancreatic tumors - pancreatic ductal adenocarcinoma, pancreatic neuroendocrine tumor, solid-pseudopapillary neoplasm, acinar cell carcinoma and pancreatoblastoma.

摘要

背景

组织学特征已被证明对胰腺不同类型肿瘤的分类非常有用。因此,胰腺中的主要肿瘤类型长期以来一直根据其微观外观进行分类。

正文

全外显子组测序、基因表达谱分析以及肿瘤发生途径知识的最新进展加深了我们对胰腺肿瘤潜在生物学特性的理解。这些进展不仅证实了传统的组织学分类系统,还为早期诊断和靶向治疗打开了新的大门。

结论

本综述讨论了五种主要恶性胰腺肿瘤——胰腺导管腺癌、胰腺神经内分泌肿瘤、实性假乳头状肿瘤、腺泡细胞癌和胰腺母细胞瘤的组织病理学、遗传和表观遗传改变以及潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/08d880b9f050/13000_2016_497_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/d0ab5ce367f4/13000_2016_497_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/6b0eaceba218/13000_2016_497_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/998f940a38de/13000_2016_497_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/8d74f8f10f9a/13000_2016_497_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/0055ac18709f/13000_2016_497_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/5529e4c2544a/13000_2016_497_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/0fef1f74b707/13000_2016_497_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/08d880b9f050/13000_2016_497_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/d0ab5ce367f4/13000_2016_497_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/6b0eaceba218/13000_2016_497_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/998f940a38de/13000_2016_497_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/8d74f8f10f9a/13000_2016_497_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/0055ac18709f/13000_2016_497_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/5529e4c2544a/13000_2016_497_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/0fef1f74b707/13000_2016_497_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e1/4897815/08d880b9f050/13000_2016_497_Fig8_HTML.jpg

相似文献

1
Surgical and molecular pathology of pancreatic neoplasms.胰腺肿瘤的外科与分子病理学
Diagn Pathol. 2016 Jun 7;11(1):47. doi: 10.1186/s13000-016-0497-z.
2
Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report.胃混合性神经内分泌-非神经内分泌肿瘤(MiNEN)伴胰腺腺泡分化:病例报告。
Diagn Pathol. 2019 May 10;14(1):38. doi: 10.1186/s13000-019-0815-3.
3
Non-Ductal Tumors of the Pancreas.胰腺非导管性肿瘤
Monogr Clin Cytol. 2020;26:92-108. doi: 10.1159/000455737. Epub 2020 Sep 28.
4
Presentation and outcome of mixed neuroendocrine non-neuroendocrine neoplasms of the pancreas.胰腺混合性神经内分泌-非神经内分泌肿瘤的临床表现及转归
Pancreatology. 2021 Jan;21(1):224-235. doi: 10.1016/j.pan.2020.11.020. Epub 2020 Dec 3.
5
Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.胰腺具有腺泡分化的肿瘤的全外显子组测序。
J Pathol. 2014 Mar;232(4):428-35. doi: 10.1002/path.4310.
6
Pathology and Molecular Characteristics of Pancreatic Cancer.胰腺癌的病理学和分子特征。
Surg Oncol Clin N Am. 2021 Oct;30(4):609-619. doi: 10.1016/j.soc.2021.06.003. Epub 2021 Jul 22.
7
Molecular Genetics of Pancreatic Neoplasms.胰腺肿瘤的分子遗传学
Surg Pathol Clin. 2016 Dec;9(4):685-703. doi: 10.1016/j.path.2016.05.011. Epub 2016 Oct 12.
8
BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens.BCL10 作为胰腺腺泡细胞癌的一个有用标志物,尤其在使用内镜超声细胞学标本时。
Pathol Int. 2013 Mar;63(3):176-82. doi: 10.1111/pin.12045.
9
PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.PAX8 的表达能可靠地区分胰腺高分化神经内分泌肿瘤与回肠和肺高分化神经内分泌肿瘤及胰腺腺泡细胞癌。
Mod Pathol. 2011 Mar;24(3):412-24. doi: 10.1038/modpathol.2010.176. Epub 2010 Oct 1.
10
Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration.经内镜超声引导下细针抽吸标本对胰腺肿瘤的诊断方法。
Pathol Int. 2010 May;60(5):358-64. doi: 10.1111/j.1440-1827.2010.02527.x.

引用本文的文献

1
Evaluation of the Value of Fine Needle Aspiration Cytology and Cell Morphology in Determining the Histogenesis of Pancreatic Lesions With Review of Literature, Overview and Cytological Experience of 25 Years: Original Research.细针穿刺细胞学检查及细胞形态学在确定胰腺病变组织发生中的价值评估:文献综述、25年概述及细胞学经验:原创研究
Health Sci Rep. 2025 Jan 12;8(1):e70347. doi: 10.1002/hsr2.70347. eCollection 2025 Jan.
2
The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms.肿瘤微环境和免疫检查点在胰腺神经内分泌肿瘤中的预后和治疗价值。
Sci Rep. 2024 Oct 21;14(1):24669. doi: 10.1038/s41598-024-75882-4.
3

本文引用的文献

1
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.全基因组测序确定家族性胰腺癌的遗传异质性。
Cancer Discov. 2016 Feb;6(2):166-75. doi: 10.1158/2159-8290.CD-15-0402. Epub 2015 Dec 9.
2
A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.巴尔的摩胰腺肿瘤前体病变共识会议的修订分类系统及建议
Am J Surg Pathol. 2015 Dec;39(12):1730-41. doi: 10.1097/PAS.0000000000000533.
3
The mini-driver model of polygenic cancer evolution.
Unbiased Quantitative Proteomics of Organoid Models of Pancreatic Cancer.
胰腺癌类器官模型的无偏定量蛋白质组学研究
Methods Mol Biol. 2024;2823:77-93. doi: 10.1007/978-1-0716-3922-1_6.
4
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals.意大利胰腺癌高危家族登记研究(IRFARPC):高危人群胰腺癌监测国家项目的实施和演变。
Fam Cancer. 2024 Aug;23(3):373-382. doi: 10.1007/s10689-024-00366-3. Epub 2024 Mar 16.
5
Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma.先天和适应性免疫靶向的胰腺导管腺癌肿瘤微环境。
Front Immunol. 2024 Feb 7;15:1323198. doi: 10.3389/fimmu.2024.1323198. eCollection 2024.
6
A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With Acute Pancreatitis.急性胰腺炎患者胰腺癌风险评估的临床预测模型。
Pancreas. 2024 Mar 1;53(3):e254-e259. doi: 10.1097/MPA.0000000000002295. Epub 2024 Jan 25.
7
Solid pseudopapillary neoplasms of the pancreas in childhood and adolescence-an analysis of the German Registry for Rare Pediatric Tumors (STEP).儿童和青少年胰腺实性假乳头状肿瘤-德国罕见儿科肿瘤登记处(STEP)分析。
Eur J Pediatr. 2023 Dec;182(12):5341-5352. doi: 10.1007/s00431-023-05203-w. Epub 2023 Sep 21.
8
Pancreatic metastasis of leiomyoma found 27 years after uterine fibroid surgery.子宫肌瘤手术后 27 年发现胰腺转移平滑肌瘤。
Clin J Gastroenterol. 2023 Dec;16(6):931-936. doi: 10.1007/s12328-023-01842-6. Epub 2023 Aug 26.
9
Role of Pancreatic Tumour-Derived Exosomes and Their Cargo in Pancreatic Cancer-Related Diabetes.胰腺肿瘤衍生外泌体及其 cargo 在胰腺癌相关糖尿病中的作用。
Int J Mol Sci. 2023 Jun 15;24(12):10203. doi: 10.3390/ijms241210203.
10
Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors.分析大量胰腺癌转录组谱,揭示最强的预后因素。
Clin Transl Sci. 2023 Aug;16(8):1479-1491. doi: 10.1111/cts.13563. Epub 2023 Jun 6.
多基因癌症进化的微驱动模型。
Nat Rev Cancer. 2015 Nov;15(11):680-5. doi: 10.1038/nrc3999. Epub 2015 Oct 12.
4
Genetics of pancreatic neuroendocrine tumors: implications for the clinic.胰腺神经内分泌肿瘤的遗传学:对临床的意义
Expert Rev Gastroenterol Hepatol. 2015;9(11):1407-19. doi: 10.1586/17474124.2015.1092383. Epub 2015 Sep 28.
5
Immune Therapy in Pancreatic Cancer: Now and the Future?胰腺癌的免疫治疗:现状与未来?
Rev Recent Clin Trials. 2015;10(4):317-25. doi: 10.2174/1574887110666150916142537.
6
Pathology, genetics and precursors of human and experimental pancreatic neoplasms: An update.人类及实验性胰腺肿瘤的病理学、遗传学与前驱病变:最新进展
Pancreatology. 2015 Nov-Dec;15(6):598-610. doi: 10.1016/j.pan.2015.08.007. Epub 2015 Sep 3.
7
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.虚拟显微切割鉴定出胰腺导管腺癌不同的肿瘤特异性和基质特异性亚型。
Nat Genet. 2015 Oct;47(10):1168-78. doi: 10.1038/ng.3398. Epub 2015 Sep 7.
8
Pancreatic adenocarcinoma pathology: changing "landscape".胰腺腺癌病理学:不断变化的“格局”
J Gastrointest Oncol. 2015 Aug;6(4):358-74. doi: 10.3978/j.issn.2078-6891.2015.032.
9
A combination of molecular markers and clinical features improve the classification of pancreatic cysts.分子标志物与临床特征相结合可改善胰腺囊肿的分类。
Gastroenterology. 2015 Nov;149(6):1501-10. doi: 10.1053/j.gastro.2015.07.041. Epub 2015 Aug 4.
10
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients.胰腺癌患者肿瘤及循环系统中基因组改变的临床意义。
Nat Commun. 2015 Jul 7;6:7686. doi: 10.1038/ncomms8686.